semaglutide shortage 2025 FDA declares end to Wegovy and Ozempic fda declares semaglutide shortage resolved

Cardiovascular, Liver, and Renal Benefits of GLP-1 Agonists Notably, semaglutide is not just a glucose-lowering drug, it improves weight and has proven cardiovascular, liver, and renal benefits

Its efficacy in improving concentration, focus, and control in individuals with ADHD has made it a mainstay in the therapeutic arena

However, according to the UKs Medicines and Healthcare products Regulatory Agency (MHRA), the most common side effects of GLP-1 medications are digestive issues, including constipation, diarrhoea, loss of appetite, nausea and vomiting

US clinical guidelines from organizations such as the American Diabetes Association (ADA), American Gastroenterological Association (AGA), and Endocrine Society recommend continuing effective anti-obesity medication therapy as long as it remains beneficial, well-tolerated, and medically appropriate